| Year |
Citation |
Score |
| 2020 |
Amor C, Feucht J, Leibold J, Ho YJ, Zhu C, Alonso-Curbelo D, Mansilla-Soto J, Boyer JA, Li X, Giavridis T, Kulick A, Houlihan S, Peerschke E, Friedman SL, Ponomarev V, et al. Senolytic CAR T cells reverse senescence-associated pathologies. Nature. PMID 32555459 DOI: 10.1038/S41586-020-2403-9 |
0.354 |
|
| 2019 |
Hamieh M, Dobrin A, Cabriolu A, van der Stegen SJC, Giavridis T, Mansilla-Soto J, Eyquem J, Zhao Z, Whitlock BM, Miele MM, Li Z, Cunanan KM, Huse M, Hendrickson RC, Wang X, et al. CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape. Nature. PMID 30918399 DOI: 10.1038/S41586-019-1054-1 |
0.36 |
|
| 2018 |
Clarke R, Van Der Stegen S, Chang C, Husain M, Lai Y, Peralta E, Stokely L, Abujarour R, Dinella J, Lee T, Pribadi M, Chu H, Truong C, Sabouri-Ghomi M, Meza M, ... ... Mansilla-Soto J, et al. Pluripotent Cell-Derived Off-the-Shelf TCR-Less CAR-Targeted Cytotoxic T Cell Therapeutic for the Allogeneic Treatment of B Cell Malignancies Blood. 132: 4546-4546. DOI: 10.1182/Blood-2018-99-116843 |
0.374 |
|
| 2018 |
Clarke RL, Stegen Svd, Lee T, Mansilla-Soto J, Chang C, Sasaki J, Husain M, Peralta E, Hardy I, Ortiz E, Riviere I, Sadelain M, Valamehr B. Abstract LB-108: Generation of off-the-shelf TCR-less CAR-targeted cytotoxic T cells from renewable pluripotent cells for cancer immunotherapy Immunology. 78. DOI: 10.1158/1538-7445.Am2018-Lb-108 |
0.377 |
|
| 2017 |
Perna F, Berman SH, Soni RK, Mansilla-Soto J, Eyquem J, Hamieh M, Hendrickson RC, Brennan CW, Sadelain M. Integrating Proteomics and Transcriptomics for Systematic Combinatorial Chimeric Antigen Receptor Therapy of AML. Cancer Cell. 32: 506-519.e5. PMID 29017060 DOI: 10.1016/J.Ccell.2017.09.004 |
0.323 |
|
| 2017 |
Eyquem J, Mansilla-Soto J, Giavridis T, van der Stegen SJ, Hamieh M, Cunanan KM, Odak A, Gönen M, Sadelain M. Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection. Nature. PMID 28225754 DOI: 10.1038/Nature21405 |
0.386 |
|
| 2017 |
Seyffert M, Glauser DL, Schraner EM, de Oliveira AP, Mansilla-Soto J, Vogt B, Büning H, Linden RM, Ackermann M, Fraefel C. Novel Mutant AAV2 Rep Proteins Support AAV2 Replication without Blocking HSV-1 Helpervirus Replication. Plos One. 12: e0170908. PMID 28125695 DOI: 10.1371/Journal.Pone.0170908 |
0.423 |
|
| 2016 |
Mansilla-Soto J, Riviere I, Boulad F, Sadelain M. Cell and gene therapy for the beta-thalassemias: advances and prospects. Human Gene Therapy. PMID 27021486 DOI: 10.1089/Hum.2016.037 |
0.315 |
|
| 2016 |
Perna F, Berman S, Mansilla-Soto J, Hamieh M, Juthani R, Soni R, Eyquem J, Hendrickson R, Brennan C, Sadelain M. Probing the AML Surfaceome for Chimeric Antigen Receptor (CAR) Targets Blood. 128: 526-526. DOI: 10.1182/Blood.V128.22.526.526 |
0.371 |
|
| 2016 |
Stegen SJCvd, Themeli M, Eyquem J, Mansilla-Soto J, Sadelain M. Abstract 2309: T-cell development from T cell-derived induced pluripotent stem cell Cancer Research. 76: 2309-2309. DOI: 10.1158/1538-7445.Am2016-2309 |
0.363 |
|
| 2016 |
Eyquem J, Mansilla-Soto J, Odak A, Sadelain M. 274. One-Step Generation of Universal CAR T Cells Molecular Therapy. 24: S109. DOI: 10.1016/S1525-0016(16)33083-0 |
0.385 |
|
| 2015 |
Perna F, Vu LP, Themeli M, Kriks S, Hoya-Arias R, Khanin R, Hricik T, Mansilla-Soto J, Papapetrou EP, Levine RL, Studer L, Sadelain M, Nimer SD. The polycomb group protein L3MBTL1 represses a SMAD5-mediated hematopoietic transcriptional program in human pluripotent stem cells. Stem Cell Reports. 4: 658-69. PMID 25754204 DOI: 10.1016/J.Stemcr.2015.02.003 |
0.344 |
|
| 2015 |
Mansilla-Soto J, Leifman Y, Sadelain M. 343. Repair of the Sickle-Cell Disease Mutation in Human Stem Cells Using CRISPR/Cas9 and Single-Stranded Oligodeoxynucleotides Molecular Therapy. 23: S137. DOI: 10.1016/S1525-0016(16)33952-1 |
0.392 |
|
| 2013 |
Zarate-Perez F, Mansilla-Soto J, Bardelli M, Burgner JW, Villamil-Jarauta M, Kekilli D, Samso M, Linden RM, Escalante CR. Oligomeric properties of adeno-associated virus Rep68 reflect its multifunctionality. Journal of Virology. 87: 1232-41. PMID 23152528 DOI: 10.1128/Jvi.02441-12 |
0.382 |
|
| 2012 |
Zarate-Perez F, Bardelli M, Burgner JW, Villamil-Jarauta M, Das K, Kekilli D, Mansilla-Soto J, Linden RM, Escalante CR. The interdomain linker of AAV-2 Rep68 is an integral part of its oligomerization domain: role of a conserved SF3 helicase residue in oligomerization. Plos Pathogens. 8: e1002764. PMID 22719256 DOI: 10.1371/Journal.Ppat.1002764 |
0.338 |
|
| 2011 |
Mansilla-Soto J, Rivière I, Sadelain M. Genetic strategies for the treatment of sickle cell anaemia. British Journal of Haematology. 154: 715-27. PMID 21707580 DOI: 10.1111/J.1365-2141.2011.08773.X |
0.327 |
|
| 2009 |
Mansilla-Soto J, Yoon-Robarts M, Rice WJ, Arya S, Escalante CR, Linden RM. DNA structure modulates the oligomerization properties of the AAV initiator protein Rep68. Plos Pathogens. 5: e1000513. PMID 19593381 DOI: 10.1371/Journal.Ppat.1000513 |
0.478 |
|
| 2004 |
Sawchuk DJ, Mansilla-Soto J, Alarcon C, Singha NC, Langen H, Bianchi ME, Lees-Miller SP, Nussenzweig MC, Cortes P. Ku70/Ku80 and DNA-dependent protein kinase catalytic subunit modulate RAG-mediated cleavage: implications for the enforcement of the 12/23 rule. The Journal of Biological Chemistry. 279: 29821-31. PMID 15123719 DOI: 10.1074/Jbc.M403706200 |
0.596 |
|
| 2003 |
Mansilla-Soto J, Cortes P. VDJ recombination: Artemis and its in vivo role in hairpin opening. The Journal of Experimental Medicine. 197: 543-7. PMID 12615895 DOI: 10.1084/Jem.20022210 |
0.625 |
|
| 1998 |
Besmer E, Mansilla-Soto J, Cassard S, Sawchuk DJ, Brown G, Sadofsky M, Lewis SM, Nussenzweig MC, Cortes P. Hairpin coding end opening is mediated by RAG1 and RAG2 proteins. Molecular Cell. 2: 817-28. PMID 9885569 DOI: 10.1016/S1097-2765(00)80296-8 |
0.612 |
|
| Show low-probability matches. |